Reiter Sarah 4
4 · Arcadia Biosciences, Inc. · Filed Jun 7, 2019
Insider Transaction Report
Form 4
Reiter Sarah
Chief Commercial Officer
Transactions
- Award
Stock Option (right to buy)
2019-06-03+23,305→ 71,705 totalExercise: $5.04Exp: 2029-06-03→ Common Stock (23,305 underlying)
Footnotes (1)
- [F1]The Option vests with respect to 25% of the total securities subject to the option on the first anniversary of the date of award, or June 3, 2020, with the remaining 75% vesting in 36 equal installments beginning June 30, 2020 and ending May 31, 2023, subject to the Participant's continued service.